Posted: Mon Jan 31, 2022 7:32 pm
TOKYO, Jan 31 (Reuters) - Japanese trading and pharmaceuticals company Kowa Co Ltd (7807.T) on Monday said that anti-parasite drug ivermectin showed an "antiviral effect" against Omicron and other coronavirus variants in joint non-clinical research.
https://www.reuters.com/business/health ... 022-01-31/
https://www.reuters.com/business/health ... 022-01-31/